NCT05783908 Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
| NCT ID | NCT05783908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Georges Francois Leclerc |
| Condition | Patient With Radiotherapy (Linac MRI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2025-09-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-16 with a primary completion date of 2025-09-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...). After signing the consent form, each patient will be randomized to one of two treatment arms: * Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to evaluate the effect of using a non-magnetic screen visible to the patient in the bunker during radiotherapy sessions delivered by Linac MRI on decreasing the ratio between the actual treatment time and the treatment time predicted by the machine.
Eligibility Criteria
Inclusion Criteria: * Patient is at least 18 years old * Patient starting radiotherapy on Linac MRI for a mobile cancerous lesion most often in the pancreas, liver, kidneys, adrenals, lung, supra or subdiaphragmatic adenopathy * Patient affiliated to the social security system Exclusion Criteria: * Patient with lesions not detected by the device's tracking system * Patient with visual disturbances * Contraindications to treatment with Linac MRI (epileptic patients, pregnant or breastfeeding women, metallic prosthesis or pacemaker not compatible with MRI) * Patients with cognitive disorders * Persons deprived of liberty or under guardianship (including curatorship) * Pregnant or nursing woman * Refusal to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05783908 clinical trial?
This trial is open to participants of all sexes, aged 18 Months or older, studying Patient With Radiotherapy (Linac MRI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05783908 currently recruiting?
Yes, NCT05783908 is actively recruiting participants. Contact the research team at gtruc@cgfl.fr for enrollment information.
Where is the NCT05783908 trial being conducted?
This trial is being conducted at Dijon, France.
Who is sponsoring the NCT05783908 clinical trial?
NCT05783908 is sponsored by Centre Georges Francois Leclerc. The trial plans to enroll 100 participants.